Indrayani Biotech Dirección

Dirección controles de criterios 3/4

El CEO de Indrayani Biotech es Kasiraman Sundar, nombrado en Feb 2018, tiene una permanencia de 6.75 años. posee directamente un 5.78% de las acciones de la empresa, con un valor de ₹97.53M. La antigüedad media del equipo directivo y de la junta directiva es de 4 años y 5.3 años, respectivamente.

Información clave

Kasiraman Sundar

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	6.8yrs
Participación del CEO	5.8%
Permanencia media de la dirección	4yrs
Promedio de permanencia en la Junta Directiva	5.3yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Kasiraman Sundar (63 yo)

6.8yrs

Permanencia

Mr. Kasiraman Sayee Sundar has been Executive Director and Managing Director of Indrayani Biotech Ltd since February 17, 2018. He has experience in Real Time Embedded Systems & Firmware Development and was...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Kasiraman Sundar	MD & Executive Director	6.8yrs	sin datos	5.78% ₹ 97.5m
Singarababu Indirakumar	Whole Time Director	4.3yrs	₹1.83m	sin datos
G. Swaminathan	Whole-Time Director	4.3yrs	sin datos	9.09% ₹ 153.4m
Muthukrishnan Ramesh	Whole Time Director	3.6yrs	₹2.82m	2.31% ₹ 38.9m
Vinayaka Bodala	Chief Financial Officer	3.8yrs	sin datos	sin datos
V. Santhanakrishnan	Company Secretary & Compliance Officer	less than a year	sin datos	sin datos
Mary Sujatha	Head of Human Resource	no data	sin datos	sin datos
Dhinakaran Rajagopal	Chief Co-ordinating Officer	no data	sin datos	sin datos

4.0yrs

Permanencia media

56.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 526445 se considera experimentado (4 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Kasiraman Sundar	MD & Executive Director	6.8yrs	sin datos	5.78% ₹ 97.5m
Singarababu Indirakumar	Whole Time Director	4.3yrs	₹1.83m	sin datos
G. Swaminathan	Whole-Time Director	4.3yrs	sin datos	9.09% ₹ 153.4m
Muthukrishnan Ramesh	Whole Time Director	3.8yrs	₹2.82m	2.31% ₹ 38.9m
Nangavaram Ranganathan	Independent Chairman of the Board	6.3yrs	sin datos	sin datos
Kannimangalam Vaidyanathan	Independent Director	6.3yrs	sin datos	0.022% ₹ 370.6k
Lakshmiprabha Kasiraman	Non Independent Non-Executive Women Director	6.3yrs	sin datos	0.0077% ₹ 129.8k
Bokara Nagarajan Priyadharshini	Independent Director	3.7yrs	sin datos	sin datos

5.3yrs

Permanencia media

61yo

Promedio de edad

Junta con experiencia: La junta directiva de 526445 se considera experimentada (5.3 años de antigüedad promedio).

Indrayani Biotech Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Indrayani Biotech Limited, Annual General Meeting, Aug 22, 2024

Insufficient new directors

Indrayani Biotech Limited Announces Company Secretary & Compliance Officer Changes

Indrayani Biotech Limited Announces Executive Changes

Indrayani Biotech Limited, Annual General Meeting, Sep 30, 2022

Indrayani Biotech Limited Approves Constitution the Allotment Committee

Recent updates

Investor sentiment improves as stock rises 21%

First quarter 2025 earnings released: EPS: ₹0.10 (vs ₹0.09 loss in 1Q 2024)

Indrayani Biotech Limited to Report Q1, 2025 Results on Aug 14, 2024

Indrayani Biotech Limited, Annual General Meeting, Aug 22, 2024

Investor sentiment improves as stock rises 15%

Full year 2024 earnings released: EPS: ₹1.40 (vs ₹2.55 in FY 2023)

Now 23% undervalued after recent price drop

Now 20% undervalued after recent price drop

Investor sentiment improves as stock rises 21%

Now 21% undervalued after recent price drop

Insufficient new directors

New minor risk - Share price stability

Investor sentiment improves as stock rises 16%

Indrayani Biotech Limited Announces Company Secretary & Compliance Officer Changes

Second quarter 2024 earnings released: EPS: ₹0.89 (vs ₹1.54 in 2Q 2023)

New minor risk - Shareholder dilution

Indrayani Biotech Limited to Report Q3, 2024 Results on Feb 14, 2024

First quarter 2024 earnings released: ₹0.09 loss per share (vs ₹0.52 profit in 1Q 2023)

Indrayani Biotech Limited to Report Q1, 2024 Results on Aug 11, 2023

New major risk - Financial position

New major risk - Earnings quality

Full year 2023 earnings released: EPS: ₹5.95 (vs ₹1.30 in FY 2022)

Indrayani Biotech Limited to Report Q4, 2023 Results on May 30, 2023

Indrayani Biotech Limited Announces Executive Changes

Investor sentiment improves as stock rises 19%

Third quarter 2023 earnings released: EPS: ₹0.72 (vs ₹0.33 in 3Q 2022)

Indrayani Biotech Limited (BSE:526445) acquired 51% stake in Matrix Boilers Private Limited for INR2.8 million.

Investor sentiment improved over the past week

Indrayani Biotech Limited to Report Q2, 2023 Results on Nov 14, 2022

Investor sentiment deteriorated over the past week

Indrayani Biotech Limited, Annual General Meeting, Sep 30, 2022

Investor sentiment improved over the past week

Indrayani Biotech Limited to Report Q1, 2023 Results on Aug 13, 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Indrayani Biotech Limited to Report Q4, 2022 Results on May 30, 2022

Indrayani Biotech Limited announced that it has received INR 235.16798 million in funding

Indrayani Biotech Limited Approves Constitution the Allotment Committee

Indrayani Biotech Limited Announces Management Changes

Indrayani Biotech Limited Appoints Krishnamurthi Ravichandran as the Secretarial Auditor of the Company for the Financial Year 2021-22

Indrayani Biotech Limited to Report Q3, 2022 Results on Feb 14, 2022

Indrayani Biotech Limited Appoints Muthu Krishnan Ramesh as Additional Director

Indrayani Biotech Limited to Report Fiscal Year 2020 Results on Nov 28, 2020

Indrayani Biotech Limited to Report Q1, 2021 Results on Aug 29, 2020

CEO

Permanencia

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad